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Abstract. The aim of this study was to explore the efficacy and acceptance of virtual 
reality-based software for pain reduction (VirtualPain) in a 53-year-old female with 
fibromyalgia (FM), a chronic pain syndrome. Treatment consisted of four 60-minute 
sessions. Each session involved 40 minutes of cognitive behavioral therapy (CBT) 
and 20 minutes of exposure to VirtualPain software. VirtualPain consists of a 
recreation of the human body in which the pain or lack of pain experienced by the 
participant in each body part (e.g., hand or knee) is represented by color, movement 
and sound. During exposure, the patient modified these characteristics to increase 
her sensation of control over the pain. In our study, the software was displayed on a 
stereoscopic laptop with a 17’ screen. Pain intensity was assessed on a visual analog 
scale (VAS, from 0 to 10). Before and after the treatment, the patient completed the 
Pain Anxiety Symptoms Scale Short Form (PASS-20), the Pain Catastrophizing 
Scale (PCS) and the Pain Self-Efficacy Scale (CPSS). During each session, the 
patient reported the amount of extra medication for pain consumed during the week. 
Follow-up was conducted at 6 and 12 months. The patient showed a substantial 
reduction in anxiety, catastrophic thoughts and pain perception, and improved self-
efficacy after treatment. Most importantly, at 6-month follow-up (after six months 
without treatment) results were maintained, but at 12-month follow-up (after the 
patient had been allowed to use VirtualPain at home for 6 months) the clinical 
improvements increased. The addition of VirtualPain to a CBT intervention reduced 
pain intensity and psychological symptoms (anxiety, catastrophism and low self-
efficacy) in a patient with FM. Controlled studies with large samples are now needed 
to assess the specific additional contribution of VirtualPain to CBT in the treatment 
of fibromyalgia.  





Fibromyalgia (FM) is a disabling disorder, with a population prevalence of 2.4% 
[1]. The most common symptoms are generalized pain throughout the body, paresthesia 
of the limbs, fatigue, sleep disturbances and concentration difficulties [2, 3]. The 
perception of pain is not only a physical phenomenon; it also involves emotional and 
psychological variables. Patients’ attitudes, beliefs, expectancies, thoughts, learning 
history and socio-cultural context must all be borne in mind [4, 5]. Patients must assess 
the level of demand of a situation and their personal resources in order to learn how to 
cope with this stressful experience [6]. Patients suffering from FM have a maladaptive
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coping style, as well as an external locus of control. They believe that they are powerless 
to reduce their pain [7], which lowers their quality of life and increases the pain intensity 
[8]. Cognitive-behavioral therapy (CBT) is the most effective psychological treatment 
for reducing depressive symptoms and catastrophizing and enhancing perceived self-
efficacy [9]. Virtual reality (VR) has demonstrated efficacy in the reduction of acute [10, 
11] and chronic pain [12]. However, information on its use in the treatment of FM is still 
lacking [13].  
In VirtualPain, the participant manipulates three variables which embody the 
pain experienced in different parts of his/her own body: color, speed of movement, and 
sound. The software allows the patient to tailor his/her perception of pain and represent 
it in a 3D avatar [14]. First, the patient selects the color that best represents his/her 
perception of pain and the color that best represents the absence of pain. Any color can 
be chosen. Using this information, the software itself generates a pain continuum from 0 
(color of absence of pain) to 10 (color of pain). Second, the participant chooses the sound 
from a selection representing either the countryside or the beach that best represents the 
absence of pain. The sensations of pain and rigidity are represented by the sound of 
cracking wood. Sound values range from 0 (the sound of absence of pain: countryside or 
beach) to 10 (the sound of pain). Finally, the user selects one of the 27 painful body areas 
drawn from the updated diagnosis of FM, proposed by Wolfe [3]. Each selected body 
part has a movement speed which varies according to the self-reported individual’s 
perception from 0 to 10. A score of 0 represents smooth speed, and a score of 10 a severe 
speed reduction. To sum up, the virtual environment provides a representation of 
individuals’ pain through three continuous features of parts of the avatar’s body: color 
(pain and absence of pain), movement (speed) and sound (cracking wood vs. countryside 
or beach). Once the features of pain and absence of pain have been established, the 
patient is asked to rate, on a visual analogue scale (VAS) from 0 (no pain) to 10 (extreme 
pain), the level of pain experienced in a specific body part. Then, the software gives the 
appropriate color, sound and movement to the selected body part according to the VAS 
score.  
In the case study, VirtualPain was used with three main aims. The first was to 
assess the acceptability and usability of the software in a patient with FM. The second 
was to assess the efficacy of the software in combination with CBT to reduce perceived 
pain intensity and associated symptomatology (catastrophism, anxiety and low self-
efficacy). Additionally, extra medication for pain consumption was evaluated. Finally, 
the third aim was to determine the specific efficacy of the software when it was used 
without CBT.  
  
 
2. Method  
 
Patient data 
The patient was a 53-year-old woman who lived with her husband and two 
daughters. She had an active job. The patient identified the first symptoms of FM 19 
years ago, but the official diagnosis was made 16 years ago. Her daily medication is 
Triptizol (0/0/1) and Dolocatil 1g (1/0/0). 
Description of the treatment 
A weekly one-hour session was conducted for four weeks. During the first 40 
minutes of each session, CBT techniques were applied and, during the last 20 minutes, 
the patient was exposed to VirtualPain. CBT consisted of psychoeducation about the 
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FM’s symptomatology and the causes of pain, and coping skills training. Exposure 
to VirtualPain consisted of three steps. First, the patient specified the features of pain 
and absence of pain (color, sound and movement). Second, the patient selected a body 
part (the most painful one at that moment) and reported the level of pain experienced on 
a VAS from 0 to 10; with this information, the software gave a color, sound and 
movement to the selected body part. Third, the patient was encouraged to feel as if she 
was the avatar and, eventually, to modify its characteristics (color, sound and speed of 
movement) using three slides displayed on the screen. Thus, by modifying the virtual 
representation of the pain, the patient could also modify the perception of its intensity. 
In each session, the patient was exposed to a minimum of one painful area. When the 
pain intensity was less than 40% of the pain that was initially reported, the patient could 
choose another body part to work on.  
The virtual body was displayed on a 3D laptop with specific software to create 
a stereoscopic effect that was duly processed by polarized glasses. Headphones were also 
used. In order to clarify the specific effect of VR exposure, an AB method was used 
during follow-up. Thus, during the first 6-month follow-up (phase A), the patient did not 
receive any intervention (except prescribed medication). However, during the period of 
time from follow-up at 6 months (baseline) to follow-up at 12 months (phase B), the 
therapist gave the VirtualPain software to the patient, so that she could use it at home. 
Self-efficacy, catastrophism, pain anxiety and frequency of extra pain medication were 
assessed at pre-treatment, post-treatment, 6-month follow-up and 12-month follow-up. 
At 12-month follow-up, the acceptability and usability of the VirtualPain software were 
also assessed.  
 
Measures 
The Pain Anxiety Symptoms Scale Short Form (PASS) [15] measures anxiety 
experienced with pain. Subsets of the questionnaire are cognitive anxiety (α = .86), 
escape-avoidance (α = .75), fear (α = .82), physiological anxiety (α = .81) and total 
anxiety (α = .91). The scale has 20 items rated with a Likert scale of 0 to 5. 
Chronic Pain Self-Efficacy Scale (CPSS) [16] is a questionnaire to measure 
expectations of pain. This scale has 22 items, which are divided into 3 factors: self-
efficacy for pain management (PSE) (α=.86), self-efficacy for coping with symptoms 
(CSE) (α=.91) and self-efficacy for physical function (FSE) (α=.91). 
The Pain Catastrophizing Scale (PCS) [17] assesses catastrophic thoughts related to 
pain. Its 13 items are scored on a Likert scale of 5 points (0 = not at all, 5 = all the time). 
The questionnaire has a total score (α = .87) and three subscales: rumination (α = .87), 
magnification (α = .66) and helplessness (α = .78).  
Pain intensity was assessed by means of a visual analogue scale (VAS) [18] ranging 
from 0 (no pain) to 10 (extreme pain). 
The frequency of extra medication was recorded using a weekly self-report sheet. 
 
The acceptance and usability of software were assessed by means of four VAS-based 
questions, scored from 0 (do not agree) to 10 (agree absolutely) addressing the level of 
pleasantness, usability, usefulness and realism of the software.   
 
 
3. Results  
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One of the main objectives of this study was to assess the efficacy in FM treatment 
of an intervention consisting of cognitive-behavioral techniques and exposure to 
VirtualPain, and to explore the specific effect of administrating VirtualPain alone. As 
shown in Table 1, perceived pain intensity diminished during exposure sessions.  
 
 
Table 1. Exposure to VirtualPain 
 
 Session 1  Session 2  Session 3  Session 4  
 Pre Post Time Pre Post Time Pre Post Time Pre Post Time 
Mean 3.29 2.10 171 1.01 .36 80 6.07 3.09 194 6.17 2.39 215 
SD 0.55 1.36 48.93 .06 .28 28.28 .59 .64 52.71 .23 .55 29.61 
Min 2.97 .95 101 .93 .16 60 5.09 2.51 144 5.98 1.89 183 
Max 4.11 4.04 213 1.05 .55 100 6.56 4.02 280 6.49 3.002 244 
Note: SD = standard deviation; Min = minimum value of pain; Max = maximum value of pain; Pre = 
measure of pain (VAS) before exposure to VirtualPain; Post = measure of pain (VAS) after exposure to 
VirtualPain; Time = time of exposure of VirtualPain. 
 
Likewise, pain anxiety, low self-efficacy and catastrophic thoughts were 
substantially reduced at post-treatment (Table 2). Most importantly, at 6-month follow-
up (phase A) the results were mostly maintained. Only the scores for the cognitive 
anxiety subscale of PASS-20 and painlessness subscale of PCS were higher at the first 
follow-up. However, at the 12-month follow-up (phase B), the patient showed a great 
improvement in all the outcomes. All the scores on the anxiety and catastrophism 
subscales substantially diminished, and self-efficacy considerably increased. 
Furthermore, at 6-month follow-up, the patient no longer used extra medication. It is 
important to note that during phase B, the patient could self-administer VirtualPain at 
home, in contrast with phase A.  
Another aim of this study was to assess the acceptability and usability of 
VirtualPain. At 12-month follow-up, the patient declared that she was very satisfied with 
the software and reported high levels of pleasantness (9), usability (9), usefulness (10) 
and realism (10). She also expressed that she felt able to cope with pain.  
 
 
Table 2. Questionnaires of anxiety, catastrophism, self-efficacy and medication 
 
Note. Pre= measures before treatment; Post = measures after treatment; Cogn = cognitive; EE = 
escape/avoidance; Psy = psychological anxiety; Rum = rumination; Mag = magnification; Help = helplessness; 
PSE = self-efficacy for pain management; FSE = self-efficacy for physical function; CSE = self-efficacy for 
coping with symptoms (CSE); Med = medication  
 
 
4. Conclusion  
 
 PASS-20 PCS CPSS  Med 
 Cogn EE Fear Phy Rum Mag Help PSE FSE CSE  
Pre 16 10 11 12 6 3 10 200 430 510 5 
Post 11 11 6 8 0 0 0 400 690 660 3 
6-month 
follow-up 
15 11 7 3 2 1 4 400 680 690 2 
12-month 
follow-up 
3 2 0 0 0 1 4 500 880 790 0 
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This case study provides information about the efficacy of an intervention consisting 
of four sessions combining CBT techniques and virtual reality exposure using 
VirtualPain software in a 53-year-old female with FM. The patient showed a substantial 
improvement on completion of the combined treatment. Catastrophic thoughts and pain 
anxiety, which are strongly associated with pain perception [21], diminished 
considerably after treatment (CBT + VirtualPain).  
Likewise, a significant reduction in extra medication was observed. However, 
the most impressive results came from the model AB used during follow-up. At 6-month 
follow-up, after 6 months without psychological treatment, the patient maintained the 
improvement achieved post-treatment. Most interesting, at 12-month follow-up, after 
self-administering VirtualPain software for six months as the only psychological 
intervention, all the assessed variables improved much more than at 6-month follow-up, 
and the patient reported that she no longer used rescue medication. These results provide 
valuable information about the potential benefits of using VirtualPain software in FM 
treatment.  
The patient reported that she was satisfied with the software-based intervention 
and reduced her perceived pain by means of exposure to VirtualPain. Furthermore, she 
described the software as easy to manage and pleasant, which showed good acceptability. 
Other authors have reported that VR-based software is usually well-accepted for 
treatment purposes [19]. 
A major limitation of this study is that it does not include a baseline prior to 
treatment. However, an AB model was used during follow-up to establish a baseline prior 
to the self-administration (at home) of VirtualPain. In future studies, it would be 
appropriate to add more phases (ABAB) to clarify the effect of treatment and each of its 
components. Despite the limitations of this study, the results are positive and should lead 
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